Ganymed Pharmaceuticals AG

USPTO Trademark & Patent Filings

Ganymed Pharmaceuticals Ag

Trademark applications and grants for Ganymed Pharmaceuticals Ag. Ganymed Pharmaceuticals Ag has 4 trademark applications. The latest application filed is for "MEMBRANOME"

Company Profile
    Company Aliases
  • Ganymed Pharmaceuticals AG
  • ag pharmaceuticals ganymed
  • Ganymed Pharmaceuticals AG - Mainz DE
  • GANYMED PHARMACEUTICALS AG - Mainz DE
State Incorporated GERMANY
Entity Type CORPORATION
Address Freiligrathstr. 12 55131 Mainz GERMANY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
20220306711 - 17/712562 SAHIN; Ugur ;   et al.
2022-09-29
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
20190389920 - 16/444510 SAHIN; Ugur ;   et al.
2019-12-26
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
20190169614 - 16/275111 Sahin; Ugur ;   et al.
2019-06-06
Agents for Treatment of Claudin Expressing Cancer Diseases
20190055311 - 16/117197 Sahin; Ugur ;   et al.
2019-02-21
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
20190010244 - 16/028210 Sahin; Ugur ;   et al.
2019-01-10
Claudin-6-specific immunoreceptors and t cell epitopes
11,345,731 - 16/444,510 Sahin , et al. May 31, 2
2022-05-31
Claudin-6-specific immunoreceptors and t cell epitopes
11,345,731 - 16/444,510 Sahin , et al. May 31, 2
2022-05-31
Antibodies for treatment of cancer expressing claudin 6
10,919,974 - 16/028,210 Sahin , et al. February 16, 2
2021-02-16
Cancer therapy using CLDN6 target-directed antibodies in vivo
10,844,133 - 15/866,139 Sahin , et al. November 24, 2
2020-11-24
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
10,813,996 - 15/973,116 Sahin , et al. October 27, 2
2020-10-27
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed